Sinusitis Exclusion From Nasal Decongestant Labels Is Unsupported – Pfizer

Physician intervention could be the only recourse for consumers suffering from sinusitis if FDA were to remove the indication from OTC product labels, according to Pfizer Consumer Healthcare